Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation during pregnancy.

Tasneem Z Naqvi1, Elyse Foster

  • 1Division of Cardiology, Cedars-Sinai Medical Center, Room 5341, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. tasneem.naqvi@cshs.org

Current Women'S Health Reports
|July 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute haemodynamic improvement but worsening myocardial mechanics with right ventricular pacing in a patient with intrinsic left bundle branch block: a case report.

European heart journal. Case reports·2026
Same author

Time-Dependent Association Between Breast Cancer and Risk of Ischemic Stroke: A Nationwide Cohort Study.

Neurology·2026
Same author

Effect of Handheld Echocardiography by Trained Advanced Practice Providers on Heart Failure Management and Readmissions.

Mayo Clinic proceedings. Innovations, quality & outcomes·2026
Same author

Grades 1 and 2 Left Ventricular Diastolic Dysfunction: Early Right Ventricular Involvement and the Case for a Biventricular Paradigm.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Echo Combined with Cardiac Magnetic Resonance in Redefining Optimal Timing of Surgical Mitral Valve Repair: Do Conventional Criteria Endure?

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2025
Same author

Right Ventricular Apical Pacing in Patients With Preserved LVEF: Adverse Effects and Mechanisms.

JACC. Advances·2025
Same journal

Ethics of research and the pregnant patient.

Current women's health reports·2003
Same journal

Medical education and indigent patient care.

Current women's health reports·2003
Same journal

Cloning and stem cells: processes, politics, and policy.

Current women's health reports·2003
Same journal

The impact of residents' work-hour restrictions.

Current women's health reports·2003
Same journal

Misoprostol in gynecology.

Current women's health reports·2003
Same journal

Sexuality during the perimenopause.

Current women's health reports·2003
See all related articles

Anticoagulation during pregnancy, especially with mechanical valves or clotting disorders, is complex. Low molecular weight heparin shows promise as a safer option, though optimal use remains debated due to limited clinical trials.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Hematology

Background:

  • Anticoagulation is crucial for pregnant women with mechanical prosthetic valves or thrombophilic disorders to prevent thromboembolic events.
  • Increasing maternal age and prevalence of prosthetic heart valves heighten the importance of safe anticoagulation strategies during pregnancy.

Observation:

  • Current anticoagulants like warfarin and unfractionated heparin have controversial optimal use during pregnancy due to insufficient prospective randomized trials.
  • Retrospective data on heparin dosing is inadequate for clinical decision-making.
  • Low molecular weight heparin is emerging as a potentially safer alternative for anticoagulation in pregnancy.

Findings:

  • Optimal anticoagulation regimens during pregnancy, particularly for high-risk patients, are not well-established.

Related Experiment Videos

  • Evidence supporting the safety and efficacy of different anticoagulants in pregnancy is limited.
  • Low molecular weight heparin presents a promising alternative, but further research is needed.

    • Implications:

    • There is a critical need for robust clinical trials to guide anticoagulation decisions in pregnant patients.
    • Developing evidence-based guidelines for anticoagulation in pregnancy is essential for improving patient outcomes.
    • Low molecular weight heparin may offer a safer therapeutic option, warranting further investigation and clinical adoption.